Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
The DOI matches its Crossref record; 484 of the 491 references it cites were found in a registry or an index.
Abstract
Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2 diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin resistant, metformin was introduced in clinical practice to treat these patients also. Moreover, metformin's effect has other targets beside its insulin-sensitizing action. The present review was aimed at describing all evidence-based and potential uses of metformin in PCOS patients. In particular, we will analyze the uses of metformin not only for the treatment of all PCOS-related disturbances such as menstrual disorders, anovulatory infertility, increased abortion, or complicated pregnancy risk, hyperandrogenism, endometrial, metabolic and cardiovascular abnormalities, but also for the prevention of the syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the beneficial effects of metformin are increasingly evident, especially when combined with lifestyle modifications, improving the pathogenetic mechanisms underlying PCOS, restoring ovarian function, and improving metabolic profile, especially insulin sensitivity and, unlike COCs, lipoprotein pattern [49].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [49]
In the citing paper
“Metformin has been used extensively in DM2, is the most studied in PCOS, and has the most reassuring safety profile. 222”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [222]
Citations
Cites
4 retracted
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M.-H., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 478
RetractedClomiphene citrate for ovulation induction in women with oligo-amenorrhoea
Hughes, E. G., Collins, J. A., & Vandekerckhove, P. (1996) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000056 · Cited by 75
RetractedWei, Z., Cao, Y., Cong, L., Zhou, P., Zhang, Z., & Li, J. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1385 · Cited by 37
RetractedKoçak, İ., & Üstün, C. (2006) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2006.00401.x · Cited by 24
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Research works printed but not linked: 5
- 2005, American Association of Clinical Endocrinologists position statements on metabolic and cardiovascular consequences of polycystic ovary syndrome., Endocr Pract, 11, 126
- Deaton, 1991, Hyperandrogenism and uterine bleeding., Infertil Reprod Med Clin North Am, 2, 561
- 1992, Recent advances in medically assisted conception., WHO Tech Rep Ser, 820, 1
- Sonntag, 2005, Metformin alters insulin signaling and viability of human granulosa cells., Fertil Steril, 84, 1173, 10.1016/j.fertnstert.2005.04.043 · DOI
- Koschinsky, 1988, Influence of metformin on vascular cell proliferation., Diabetes Metab, 14, 566
Cited by
Items 201–300 of 426
Nemati, M., Nemati, S., Taheri, A., & Heidari, B. (2017) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2017.07.004 · Cited by 31
Jamilian, H., Jamilian, M., Foroozanfard, F., Afshar Ebrahimi, F., Bahmani, F., & Asemi, Z. (2018) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2017.1383381 · Cited by 20
“However, metformin intake may have metabolic and reproductive benefits, such as weight reduction, improved androgen levels, restoration of a normal menstrual cyclicity and ovulation [9], the consumption of it in PCOS women may be limited by gastrointestinal side effects [10].”
BackgroundRetractedPalomba, S., Costanzi, F., Caserta, D., & Vitagliano, A. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104381 · Cited by 24
Self-citationGambineri, A., & Zanotti, L. (2018) · Nucleus · doi:10.1080/19491034.2018.1509659 · Cited by 19
“In addition, at the ovarian level, insulin contributes to anovulation directly by interfering with follicular development, causing premature follicular atresia and antral follicular arrest, and indirectly by affecting the effectiveness of gonadotropins in an abnormal intraovarian environment and by increasing intraova…”
BackgroundInfluentialMoghetti, P., Carmina, E., Leo, V. D., Lanzone, A., Orio, F., Pasquali, R., & Toscano, V. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0274-y · Cited by 25
“In particular metformin can resume both regular menstruation and ovulation, while improving the metabolic alterations [50].”
BackgroundSelf-citationEfficacy of Darchini in the management of polycystic ovarian syndrome: A randomized clinical study
Khan, A. A., & Begum, W. (2018) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2018.11.005 · Cited by 22
Wu, D., Kimura, F., Takashima, A., Shimizu, Y., Takebayashi, A., Kita, N., Zhang, G., & Murakami, T. (2013) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.230.17 · Cited by 21
“The results obtained from several uncontrolled studies have indicated that metformin is effective for restoring the menstrual cycle in approximately 62% of oligomenorrheic women with PCOS (Palomba et al. 2009b).”
BackgroundMethodInfluentialIto-Yamaguchi, A., Suganuma, R., 熊耳, 敦., Hashimoto, S., Yoshida‐Komiya, H., & Fujimori, K. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.951321 · Cited by 19
Fruzzetti, F., Fidecicchi, T., Palla, G., & Gambacciani, M. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1640673 · Cited by 24
“Insulin-sensitizers such as metformin have been proposed as treatment [4], but gastrointestinal side effects limit its use [5].”
BackgroundRooney, S., & Pendry, B. A. (2014) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2014.05.001 · Cited by 21
Çınar, N., Harmancı, A., Bayraktar, M., & Yıldız, B. O. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04415.x · Cited by 20
Sun, X., Zhang, D., & Zhang, W. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-2756-5 · Cited by 18
“Although the liver is the primary target organ, MET acts on a variety of tissues, such as skeletal muscles, adipose tissue, endothelium, and the ovary [8].”
BackgroundMetformin has a direct effect on ovarian cells that is dependent on organic cation transporters
Pietro, M. D., Velázquez, C., Matzkin, M. E., Frungieri, M. B., Peña, M. G., de Zúñiga, I., Pascuali, N., Irusta, G., Bianchi, M. S., Parborell, F., et al. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110591 · Cited by 20
Diri, H., Karaburgu, S., Açmaz, B., Ünlühızarcı, K., Tanrıverdi, F., Karaca, Z., & Keleştimur, F. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1080679 · Cited by 24
Schweighofer, N., Lerchbaum, E., Trummer, O., Theiler‐Schwetz, V., Pieber, T. R., & Obermayer-Pietsch, B. M. (2014) · Pharmacogenomics · doi:10.2217/pgs.13.223 · Cited by 17
Giudice, J., Jares-Erijman, E. A., & Leskow, F. C. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300526d · Cited by 16
Should physicians prescribe metformin to women with polycystic ovary syndrome PCOS?
Duranteau, L., Lefevre, P., Jeandidier, N., Simon, T., & Christin‐Maître, S. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.12.005 · Cited by 15
“According to different meta-analysis, its ffect is not higher than placebo and lower than antiandrogen reatments [3] (Table 2).”
BackgroundChang, H. H., Hsueh, Y., Cheng, Y. W., Ou, H., & Wu, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071720 · Cited by 18
“Metformin is an off-label medication used in PCOS patients as an insulin sensitizer [9].”
BackgroundGanie, M. A., Chowdhury, S., Suri, V., Joshi, B. N., Bhattacharya, P. K., Agrawal, S., Malhotra, N., Sahay, R. K., Rozati, R., Jabbar, P. K., et al. (2021) · JMIR Research Protocols · doi:10.2196/23437 · Cited by 21
Protective effect of metformin against gentamicin induced nephrotoxicity in rabbits.
Janjua, A., Waheed, A., & Bakhtiar, S. (2014) · PubMed · Cited by 15
Falbo, A. I., Orio, F., Venturella, R., Rania, E., Materazzo, C., Tolino, A., Zullo, F., & Palomba, S. (2009) · Journal of Ovarian Research · doi:10.1186/1757-2215-2-5 · Cited by 17
“Certainly, metformin exerts systemic actions on glucose-insulin metabolism regulation [15,16], even if a cause-effect relationship between its systemic actions and improved features of PCOS has not been demonstrated yet [16].”
BackgroundResultSelf-citationHepatokines: the missing link in the development of insulin resistance and hyperandrogenism in PCOS?
Stefanaki, K., Ilias, Ι., Paschou, S. Α., & Karagiannakis, D. S. (2023) · HORMONES · doi:10.1007/s42000-023-00487-x · Cited by 15
“Interestingly, drugs that increase insulin sensitivity may exert different effects: there is dose-dependent effect of glitazones on ovarian function, while a similar effect has not been shown with metformin [28, 29].”
BackgroundHoma, L. D., Burger, L. L., Cuttitta, A. J., Michele, D. E., & Moenter, S. M. (2015) · Endocrinology · doi:10.1210/en.2015-1593 · Cited by 17
Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in PCOS
Diri, H., Bayram, F., Simsek, Y., Caliskan, Z., & Kocer, D. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.84 · Cited by 19
“Metformin in patients with PCOS acts by reducing insulin resistance in the liver, decreasing androgen secretion by adrenal glands and ovaries, and increasing the production of SHBG in the liver, thus reducing free T concentrations (7, 12, 15).”
BackgroundLong, T., Zhang, Y., Zeng, C., Zheng, S., Zhou, L., & Liu, H. (2022) · International Journal of Endocrinology · doi:10.1155/2022/9927240 · Cited by 17
“Indeed, metformin has an insulin-sensitizing effect and will lead to IR relief, weight loss, improved oligomenorrhea, and alleviated hirsutism [14].”
BackgroundZhao, Q., & He, J. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2080194 · Cited by 17
“It is prescribed for the therapeutic management of PCOS for its potential benefits [11].”
BackgroundMaharaj, S., & Amod, A. (2009) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2009.10872199 · Cited by 23
Siemienowicz, K. J., Rae, M. T., Howells, F., Anderson, C., Nicol, L. M., Franks, S., & Duncan, W. C. (2020) · iScience · doi:10.1016/j.isci.2020.101164 · Cited by 16
Zhao, J., Yang, P., Yang, H., Wang, Z.-B., El-Samahy, M. A., Wang, F., & Zhang, Y. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.05.030 · Cited by 13
Moschus ameliorates glutamate-induced cellular damage by regulating autophagy and apoptosis pathway
Xie, D., Song, C., Qin, T., Zhai, Z., Cai, J., Dai, J., Sun, T., & Xu, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-45878-7 · Cited by 16
“The antiapoptotic B-cell lymphoma 2 (Bcl-2) protein and the proapoptotic Bax protein are considered as essential effectors of apoptosis 60 .”
Lin, Y., Zeng, H., Lin, J., Peng, Y., Que, X., Wang, L., Chen, L., & Bai, N. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1328741 · Cited by 18
“Research suggests that metformin can effectively enhance insulin sensitivity and appears to mitigate insulin-mediated androgen production, alleviating hyperandrogenism in PCOS patients and improving ovarian function (Velazquez et al., 1994; Palomba et al., 2009; Pauli et al., 2011).”
BackgroundCostello, M., & Ledger, W. J. (2012) · Women s Health · doi:10.2217/whe.12.14 · Cited by 14
Tian, D., Chen, W., Xu, Q., Li, X., & Lv, Q. (2022) · Minerva Medica · doi:10.23736/s0026-4806.21.07085-3 · Cited by 17
Endometrial scratching: is it all over?
Palomba, S., & Macklon, N. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.03.018 · Cited by 13
Self-citationDipeptidyl peptidase-4 and adenosine deaminase enzyme levels in polycystic ovary syndrome
Öztürk, B., Gürbüz, A. S., Durak, İ., & Öztürk, S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1505847 · Cited by 14
“Over the last 15 years, metformin has been extensively studied in patients with PCOS, where IR plays an important role in pathogenesis [39,40].”
BackgroundWang, L., Yu, J., Yang, H., Peng, C. Y., Zhang, C., Tao, X., & Xie, H. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445587 · Cited by 14
Alkoudsi, K. T., Alqudah, R., & Basheti, I. A. (2019) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13310 · Cited by 13
The role of metformin in ovulation induction: Current status
Elnashar, A. M. (2011) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2010.10.003 · Cited by 14
Bashir, R., Wani, I. A., & Ganie, M. A. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220518150754 · Cited by 14
Myoinositol Versus Metformin in the Treatment of Polycystic Ovarian Syndrome: A Systematic Review
Bodepudi, R., Seher, S., Khan, S. A., Emmanuel, S., Kumar, V. S., Nerella, R., Ameen, B. S., Patel, D., John, J. D., & Khan, S. (2023) · Cureus · doi:10.7759/cureus.41748 · Cited by 19
Palomba, S., Vitagliano, A., Marci, R., & Caserta, D. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01125-4 · Cited by 16
“This is particularly true for metformin, a drug with systemic and local beneficial metabolic actions, and for clomiphene, an antiestrogenic drug with known deleterious effects on the uterus, at least at high dosage and after repeated administrations [39, 40].”
BackgroundSelf-citationHara, S., Takahashi, T., Amita, M., Igarashi, H., Tsutsumi, S., & Kurachi, H. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.111.090738 · Cited by 12
“Moreover, hyperinsulinemia inhibits hepatic secretion of insulin-like growth factor binding protein (IGFBP), resulting in activation of IGF bioavailability and an increase in androgen production from theca cells [7].”
BackgroundTreatment of infertility in women with polycystic ovary syndrome
Bouchard, P. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2010.03.006 · Cited by 13
“[8] Palomba S, Falbo A, Zullo F, Orio Jr F.”
BackgroundPalomba, S., Santagni, S., Daolio, J., Gibbins, K. J., Battaglia, F. A., Sala, G. B. L., & Silver, R. M. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4572-9 · Cited by 11
“It does not influence the risk of spontaneous abortion when combined with other ovulatory drugs [99, 103].”
BackgroundSelf-citationDíaz, M., López‐Bermejo, A., Sánchez‐Infantes, D., Bassols, J., de Zegher, F., & Ibáñez, L. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.04.075 · Cited by 11
García-Beltrán, C., Malpique, R., Andersen, M., Baş, F., Bassols, J., Darendelıler, F., Díaz, M., Dieris, B., Fanelli, F., Fröhlich-Reiterer, E. E., et al. (2023) · Trials · doi:10.1186/s13063-023-07593-6 · Cited by 13
Duan, L., Shirazian, S., & Zare, M. H. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.124680 · Cited by 12
Ahmed, A. F., Sharkawi, S. S., AbdelHameed, S. S., Bayoumi, A. M. A., Moussa, R. S., Alhakamy, N. A., Sadoun, H. A., Mansouri, R. A., El‐Moselhy, M. A., El‐Daly, M., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121285 · Cited by 13
Weerakiet, S., Sophonsritsuk, A., Lertvikool, S., Satirapot, C., Leelaphiwat, S., & Jultanmas, R. (2011) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2010.01507.x · Cited by 11
“The dose of metformin used for ovulation induction in PCOS women in most of the studies varied between 1500 and 2550 mg/day,(18) and most randomized clinical trials of ovulation induction in PCOS used 1500–1700 mg per day.(19) Although there has been a dose-finding study showing an optimal dosage in lowering plasma gl…”
BackgroundMethodResultInfluentialKulshreshtha, B., Gupta, N., Ganie, M. A., & Ammini, A. C. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.671394 · Cited by 10
“reduction in gluconeogenesis, decreased glucose absorption, reduction in appetite and through its effect on fatty acids and adipose tissue [1,3].”
BackgroundTalaat, B., & Ammar, I. M. M. (2018) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2018.03.005 · Cited by 10
Management of Adolescents with Polycystic Ovary Syndrome
Freemark, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2520 · Cited by 11
Smith, R. C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050591 · Cited by 10
A Systematic Review on Clinical Evidence for Topical Metformin: Old Medication With New Application
Afshar, K., Adibfard, S., Nikbakht, M. H., Rastegarnasab, F., Pourmahdi‐Boroujeni, M., & Abtahi‐Naeini, B. (2024) · Health Science Reports · doi:10.1002/hsr2.70281 · Cited by 12
Demir, B., Paşa, S., Demir, S., Tümer, C., Atay, A. E., Gül, T., & Atamer, Y. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900443 · Cited by 10
Aljofan, M., & Gaipov, A. (2019) · Electronic Journal of General Medicine · doi:10.29333/ejgm/108679 · Cited by 12
“Likewise, the use of metformin throughout pregnancy in women with polycystic ovary syndrome decreases the rates of early pregnancy loss and preterm labor; hence protecting against fetal growth restriction (34).”
Cardiovascular risk and combined oral contraceptives: clinical decisions in settings of uncertainty
Beller, J. P., & McCartney, C. R. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.01.037 · Cited by 9
Stanosz, S., von Mach-Szczypiński, J., Sieja, K., & Koœciuszkiewicz, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1693 · Cited by 9
Bailey, C. J., & Krentz, A. J. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch29 · Cited by 16
Zhang, Z., Huo, P. F., Lei, X., Xue, H., Yang, X., Le, J., & Zhang, S. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104750 · Cited by 11
Teppa-Garrán, A., Pérez-Peña, E., Sobrevía, L., & Marín, R. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167987 · Cited by 10
Kravos, N. A., Janež, A., Goričar, K., Dolžan, V., & Jensterle, M. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00660-5 · Cited by 8
“The well-established effectiveness of metformin in achieving normal menses is linked to several pathogenic mechanisms such as reducing IR and secondary hyperinsulinemia, indirect effect on the ovary and a direct effect on the endometrium [8].”
BackgroundPathophysiology of Polycystic Ovarian Syndrome
Manu, Soni, T., Victoria, V., & Prabhakar, P. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101921 · Cited by 15
Medicinal Plants and Polycystic Ovary Syndrome
Prabhu, Y. D., Gopalakrishnan, A. V., & Roopan, S. M. (2021) · Wiley eBooks · doi:10.1002/9781119682059.ch15 · Cited by 11
Moka, M. K., Sriram, D. K., & George, M. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.11.015 · Cited by 19
Lim, B. S. Y., Chen, M., Li, H., & Li, L. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16442 · Cited by 9
Zhou, Z., Chen, H., Chu, L., Zou, Q., Chen, Q., Yang, J. J., Liu, Y., & Ou, X. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01195-1 · Cited by 10
“But metformin was recommended for all PCOS patients despite of pre-treatment insulin sensitivity [24], which indicated an insulin-independent role of metformin per se.”
BackgroundPalomba, S., Molinaro, M., Ingargiola, A., & Aversa, A. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2418985 · Cited by 8
“The effectiveness of metformin has been mechanistically attributed to its beneficial action on insulin resistance with the reduction of compensatory insulin levels [26].”
InfluentialSelf-citationPolycystic ovarian syndrome: Treatment options for infertility
Thomas, S. V., & Sudharshini, S. (2016) · Current Medical Issues · doi:10.4103/0973-4651.194459 · Cited by 8
Alsadi, B. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.89961 · Cited by 9
Metformin - more than 'gold standard' in the treatment of type 2 diabetes mellitus.
Marić, A. (2010) · Diabetologia Croatica · Cited by 17
PCOS from Lifestyle to the Use of Inositol and Insulin Sensitizers
Genazzani, A. D., Prati, A., Despini, G., Marini, G. M. F., & Ricchieri, F. (2014) · ISGE series · doi:10.1007/978-3-319-03494-2_7 · Cited by 9
Metformin and other biguanides: pharmacology and therapeutic usage
Samson, S. L., & Garber, A. J. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch43 · Cited by 9
Belani, M., Shah, P., Banker, M., & Gupta, S. S. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01126-0 · Cited by 6
“However, it’s role in improving clinical pregnancy rates is under controversy and is not recommended for normo insulinemic lean or obese PCOS [11, 18, 19].”
BackgroundVarikasuvu, S. R., Pérez-López, F. R., Thangappazham, B., Raj, H., & Vykunta, A. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1998439 · Cited by 6
“With multiple sites and mechanisms of action, metformin is a commonly used first-line drug in PCOS that reduces glucose absorption and androgen levels, stimulating hepatic gluconeogenesis, restoring menstrual cyclicity, regulating abdominal fat deposition, and increasing peripheral glucose uptake and insulin sensitivi…”
BackgroundHernández‐Yero, A., Pérez, F. S., Carballo, G. O., & Cabrera‐Rode, E. (2012) · International Journal of Endocrinology · doi:10.1155/2012/382719 · Cited by 6
“The use of drugs such as metformin, which improves insulin sensitivity and decreases resistance to this hormone, has had good results in some studies with the decrease of high insulin levels and improvement of hyperandrogenism [14, 16].”
BackgroundPalomba, S., Materazzo, C., Falbo, A. I., Orio, F., Sala, G. B. L., & Sultan, C. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.876001 · Cited by 6
“There are many unsolved questions regarding metformin administration as the formulations to use, the doses to use and the treatment length, and so on [20,21].”
BackgroundInfluentialSelf-citationPalomba, S., Falbo, A. I., Russo, T., Cello, A. D., Morelli, M., Orio, F., Cappiello, F., Tolino, A., & Zullo, F. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.588749 · Cited by 6
“On the other hand, in agreement with previous studies [1], common adverse events, such as nausea, vomiting and gastrointestinal distress were observed in ∼20% of cases, especially when high dosage and fixed protocol were used.”
BackgroundResultSelf-citationPreconception Care for Women With Preexisting Type 2 Diabetes
Roman, M. A. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.1.10 · Cited by 7
Waldman, I. N., & Legro, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00026-1 · Cited by 11
Tsaltas, T. T., & Stokes, M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316084380.029 · Cited by 7
METFORMIN ATTENUATES THIOACETAMIDE INDUCED HEPATOTOXIC EFFECTS IN RATS
Kabil, S. L. (2015) · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences · doi:10.21608/ajps.2015.12564 · Cited by 6
“The biguanide, metformin, is the most widely prescribed insulin sensitizer used for therapeutic management of type 2 diabetes, exerts most of its metabolic action on the liver (Palomba et al., 2009).”
BackgroundZhao, J., Lin, J.-J., Yang, H., Zhang, W., Huang, X., & Huang, Y. (2010) · Journal of Women s Health · doi:10.1089/jwh.2009.1491 · Cited by 6
“On the contrary, OC might worsen insulin sensitivity.(13) Currently, metformin is more widely used to treat PCOS patients, especially as a pretreatment with or without OC in ovulation induction and in IVF cycles.”
Metformin treatment with or without life style changes in patients with polycystic ovary syndrome
Petrányi, G., & Zaoura-Petrányi, M. (2011) · Orvosi Hetilap · doi:10.1556/oh.2011.29045 · Cited by 5
Babaeenezhad, E., Yegane, D. F., Yarahmadi, S., Fakouri, A., & Dezfoulian, O. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01826-9 · Cited by 6
Exploring the Link Between Metabolic Syndrome and Cellulite
Adamidis, N., Papalexis, P., & Adamidis, S. (2024) · Cureus · doi:10.7759/cureus.63464 · Cited by 13
“Lifestyle interventions, including diet and exercise, are foundational in managing these conditions, as they improve insulin sensitivity, reduce androgen levels, and can help reduce the severity of cellulite by promoting healthy body composition and improving circulation [42].”
BackgroundFattah, G. A., Almohamady, M., & Hamed, D. A. (2013) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2013.05.003 · Cited by 6
Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention
Mani, H., Khunti, K., Levy, M. J., & Davies, M. J. (2013) · Diabetes Management · doi:10.2217/dmt.13.54 · Cited by 5
Hu, L., Wang, B., & Tao, Y. (2020) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v19i9.20 · Cited by 5
“It ameliorates reproductive endocrine disorders and metabolic abnormalities in patients, promotes intestinal absorption of glucose, inhibits output of liver glycogen, and reduces liver glycogenesis [5].”
BackgroundKrysiak, R. G., Kowalcze, K. E., & Okopień, B. (2022) · Gynecologic and Obstetric Investigation · doi:10.1159/000527365 · Cited by 4
Polycystic Ovarian Syndrome: Metformin or Thiazolidinediones for Cardiovascular Risk Reduction?
Janci, M. M., Smith, R. C., & Odegard, P. S. (2012) · Diabetes Spectrum · doi:10.2337/diaspect.25.4.229 · Cited by 7
Palomba, S., & Sala, G. B. L. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.11.040 · Cited by 4
“However, our previous randomized controlled trial showed the superiority of metformin in terms of reproductive outcomes when compared with CC administered using a standard regimen (150 mg daily).(3)”
BackgroundMethodSelf-citationEditorial: PCOS: from infertility to pregnancy
Palomba, S., & Dewailly, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1220014 · Cited by 5
Self-citationHuang, W., Liu, C., Ding, L., Li, Y., Zhou, H., Wang, S., & Yang, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1327041 · Cited by 6
The cutting-edge progress of novel biomedicines in ovulatory dysfunction therapy
Liang, X., Zhang, S., Li, D., Liang, H., Yao, Y., Xia, X., Yu, H., Jiang, M., Yang, Y., Gao, M., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.008 · Cited by 4
“Metformin, as an insulin sensitizer, could inhibit hepatic gluconeogenesis, and reduced insulin levels by activating the adenosine 5 ′ -mono- phosphate (AMP)-activated protein kinase (AMPK) pathway, thereby improving local androgen synthesis in the ovary 51,52 .”
Palacios, P. C. G., Moscona-Nissan, A., Saucedo, R., & Ferreira‐Hermosillo, A. (2025) · Metabolites · doi:10.3390/metabo15040260 · Cited by 5
Polycystic ovary syndrome: why there is no cure
Vrbíková, J. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.41 · Cited by 4
Defining prediabetes in polycystic ovarian syndrome
Trolice, M. P. (2011) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2011.12008 · Cited by 7
“While obesity, type 2 diabetes mellitus (T2DM), and the metabolic syndrome are all disorders of energy balance and AMPK appears to regulate this system, perhaps the role of metformin in improving the metabolic syndrome is through this mechanism [7].”
BackgroundLin, Z., Sui, X., Li, L., Wang, Y., & Zhao, J. (2022) · Medicine · doi:10.1097/md.0000000000029765 · Cited by 5
Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes
Nicoll, J. A. R., & Buehrer, B. M. (2020) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s243154 · Cited by 4
“tolerance, it is often prescribed off-label for PCOS patients with hyperinsulinemia.(54,55) In the absence of direct clinical data, anecdotal reports by PCOS patients with severe acne suggest that at the initiation of metformin treatment to improve insulin resistance, some have suffered from acne flare-up.”
Background
Metadata
- Authors
- Palomba, S., Falbo, A., Zullo, F., & Orio, F.
- Affiliations
- Magna Graecia University (IT)
- Parthenope University of Naples (IT)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-12-04
- Volume
- 30
- Issue
- 1
- Pages
- 1-50
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2160472557
- Cited by
- 426
- References
- 491
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 20 · 2023: 28 · 2022: 25 · 2021: 18 · 2020: 15 · 2019: 19 · 2018: 19 · 2017: 15 · 2016: 18 · 2015: 26 · 2014: 37 · 2013: 40 · 2012: 33
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- CINECA IRIS Institutial research information system (Parthenope University of Naples) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- metformin, polycystic ovary syndrome, insulin sensitization, insulin resistance, menstrual disorders, anovulatory infertility, pregnancy complications, hyperandrogenism, endometrial abnormalities, cardiovascular risk, PCOS prevention, type 2 diabetes
- MeSH terms
- Anovulation, Cardiovascular Diseases, Endometrium, Female, Humans, Hypoglycemic Agents, Menstruation Disturbances, Metformin, Obesity, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Complications, Quality of Life, Endometrial Neoplasms, Hyperandrogenism, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.